9QJ-24370-02426
3 vaccinations
0 coded responses
13 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 007 / PR
- Registered
- 2021-04-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-31
Dose 1 — Moderna
-
2021-04-15
Registered in v-safe
- 2021-04-16
- 2021-04-21
-
2021-04-28
Dose 2 — Moderna
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · HeadacheAdult check-in
- 2021-05-02
- 2021-05-03
- 2021-05-12
- 2021-05-21
- 2021-10-29
-
2022-02-17
Dose 3 — Pfizer-BioNTech
- 2022-04-30
- 2022-08-20
- 2023-02-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Moderna | |
| 2 | 2021-04-28 | Moderna | |
| 3 | 2022-02-17 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.